requiring bond from pharmaceutical companies providing vaccines.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2021
Last action Nov 15, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
10
Key actions
0
Committee
6
Nov 15, 2021
House · Reported by committee
Minority Committee Report: Inexpedient to Legislate
Nov 15, 2021
House · Reported by committee
Majority Committee Report: Refer for Interim Study HB592-FN 10/29/2021 (Vote 10-9; RC) HC 48 P. 22
Oct 6, 2021
House · Reported by committee
Subcommittee Work Session: 10/12/2021 09:00 am LOB 301-303
Aug 17, 2021
House · Reported by committee
Subcommittee Work Session: 09/21/2021 02:30 pm LOB 302-304
Mar 9, 2021
House · Reported by committee
Retained in Committee
Jan 27, 2021
House · Reported by committee
Public Hearing: 02/03/2021 02:45 pm Members of the public may attend using the following link:To join the webinar: https://www.zoom.us/j/91813981191 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened.
Jan 13, 2021
House · Introduced
Introduced (in recess of) 01/06/2021 and referred to Commerce and Consumer Affairs HJ 2 P. 55
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Jeffrey Greeson
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 592
Scope: NH
Hi! I can help you understand HB 592. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline